Managing superficial bladder cancer

An overview

M. S. Soloway

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

More than 90 percent of bladder cancers are transitional cell carcinoma (TCC). Superficial TCC is defined as a transitional cell tumor that is confined to the mucosa (Stages T(a) or carcinoma in situ) or that has invaded the lamina propria (Stage T1). When treating patients with superficial bladder cancer, urologists are faced with a number of important tasks. First, the initial tumor or tumors must be removed. Second, the other parts of the urothelium must be assessed for the presence of premalignant or malignant abnormalities. Third, the depth and extent of invasion (i.e., tumor stage) must be determined. Fourth, the clinician must decide whether additional treatment (e.g., intravesical chemotherapy or immunotherapy, cystectomy, or radiotherapy) is indicated. Finally, the patient must be monitored for the development of subsequent tumors. This article provides an overview of the management of superficial bladder cancer.

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalUrology
Volume40
Issue number6 SUPPL.
StatePublished - Dec 1 1992
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Transitional Cell Carcinoma
Neoplasms
Mucous Membrane
Urothelium
Cystectomy
Carcinoma in Situ
Immunotherapy
Radiotherapy
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Soloway, M. S. (1992). Managing superficial bladder cancer: An overview. Urology, 40(6 SUPPL.), 5-10.

Managing superficial bladder cancer : An overview. / Soloway, M. S.

In: Urology, Vol. 40, No. 6 SUPPL., 01.12.1992, p. 5-10.

Research output: Contribution to journalArticle

Soloway, MS 1992, 'Managing superficial bladder cancer: An overview', Urology, vol. 40, no. 6 SUPPL., pp. 5-10.
Soloway MS. Managing superficial bladder cancer: An overview. Urology. 1992 Dec 1;40(6 SUPPL.):5-10.
Soloway, M. S. / Managing superficial bladder cancer : An overview. In: Urology. 1992 ; Vol. 40, No. 6 SUPPL. pp. 5-10.
@article{72d61a8294c448339b3dc87b6a8f292a,
title = "Managing superficial bladder cancer: An overview",
abstract = "More than 90 percent of bladder cancers are transitional cell carcinoma (TCC). Superficial TCC is defined as a transitional cell tumor that is confined to the mucosa (Stages T(a) or carcinoma in situ) or that has invaded the lamina propria (Stage T1). When treating patients with superficial bladder cancer, urologists are faced with a number of important tasks. First, the initial tumor or tumors must be removed. Second, the other parts of the urothelium must be assessed for the presence of premalignant or malignant abnormalities. Third, the depth and extent of invasion (i.e., tumor stage) must be determined. Fourth, the clinician must decide whether additional treatment (e.g., intravesical chemotherapy or immunotherapy, cystectomy, or radiotherapy) is indicated. Finally, the patient must be monitored for the development of subsequent tumors. This article provides an overview of the management of superficial bladder cancer.",
author = "Soloway, {M. S.}",
year = "1992",
month = "12",
day = "1",
language = "English",
volume = "40",
pages = "5--10",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6 SUPPL.",

}

TY - JOUR

T1 - Managing superficial bladder cancer

T2 - An overview

AU - Soloway, M. S.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - More than 90 percent of bladder cancers are transitional cell carcinoma (TCC). Superficial TCC is defined as a transitional cell tumor that is confined to the mucosa (Stages T(a) or carcinoma in situ) or that has invaded the lamina propria (Stage T1). When treating patients with superficial bladder cancer, urologists are faced with a number of important tasks. First, the initial tumor or tumors must be removed. Second, the other parts of the urothelium must be assessed for the presence of premalignant or malignant abnormalities. Third, the depth and extent of invasion (i.e., tumor stage) must be determined. Fourth, the clinician must decide whether additional treatment (e.g., intravesical chemotherapy or immunotherapy, cystectomy, or radiotherapy) is indicated. Finally, the patient must be monitored for the development of subsequent tumors. This article provides an overview of the management of superficial bladder cancer.

AB - More than 90 percent of bladder cancers are transitional cell carcinoma (TCC). Superficial TCC is defined as a transitional cell tumor that is confined to the mucosa (Stages T(a) or carcinoma in situ) or that has invaded the lamina propria (Stage T1). When treating patients with superficial bladder cancer, urologists are faced with a number of important tasks. First, the initial tumor or tumors must be removed. Second, the other parts of the urothelium must be assessed for the presence of premalignant or malignant abnormalities. Third, the depth and extent of invasion (i.e., tumor stage) must be determined. Fourth, the clinician must decide whether additional treatment (e.g., intravesical chemotherapy or immunotherapy, cystectomy, or radiotherapy) is indicated. Finally, the patient must be monitored for the development of subsequent tumors. This article provides an overview of the management of superficial bladder cancer.

UR - http://www.scopus.com/inward/record.url?scp=0027054534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027054534&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 5

EP - 10

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6 SUPPL.

ER -